Earnings
CRNX
14.36
+9.87%
1.29
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
40.33M
78.07M
--
--
--
--
1.38M
--
--
--
3.57M
--
123.34M
6.46M
--
--
--
--
--
--
582.00K
7.04M
130.38M
--
--
0.00
--
--
--
4.77M
--
3.57M
--
--
--
--
8.34M
0.00
--
--
--
4.90M
4.90M
13.24M
210.79M
--
-93.80M
--
--
--
117.14M
117.14M
130.38M
FY 2018-12-31
44.97M
118.90M
--
--
--
--
1.58M
--
--
--
1.22M
1.22M
166.68M
4.23M
--
--
--
--
--
--
500.00K
4.73M
171.41M
--
1.46M
0.00
--
--
--
--
--
6.47M
--
--
--
--
7.92M
0.00
--
--
--
3.27M
3.27M
11.19M
24.00K
203.52M
-43.38M
--
--
--
160.22M
160.22M
171.41M
FY 2017-12-31
14.19M
--
--
--
--
--
734.00K
--
--
--
239.00K
98.00K
15.16M
400.00K
--
--
--
--
--
--
33.00K
433.00K
15.60M
--
403.00K
0.00
--
--
--
--
--
494.00K
--
--
--
--
897.00K
0.00
--
--
--
23.00K
23.00K
920.00K
5000.00
1.24M
-16.27M
--
--
--
14.68M
-15.02M
15.60M
FY 2016-12-31
12.15M
--
--
--
--
--
72.00K
--
--
--
141.00K
43.00K
12.37M
224.00K
--
--
--
--
--
--
10.00K
234.00K
12.60M
--
340.00K
0.00
--
--
--
--
--
501.00K
--
--
--
--
890.00K
163.00K
--
--
--
10.00K
173.00K
1.06M
17.74M
900.00K
-7.11M
--
--
--
11.54M
11.54M
12.60M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CRNX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Crinetics Pharmaceuticals recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.